fig6

Figure 6. Proposed pathway of gliomagenic alteration of expression pattern of important early phase phenotypic markers in ENU induced glioma-bearing rats and their modulation following T11TS therapy hints towards immunocompetence against immune suppressive glioma. ENU: N-ethyl-N-nitrosourea